Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type
Offers the superior benefits of intranasal administration
Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
Requires only single-nostril administration—low dose of 0.5 mL
Provides rapid protection beginning as early as 48 hours post-vaccination against B. bronchiseptica14
Proven 1-year duration of immunity for B. bronchiseptica15
INDICATIONS:
This product has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica.
NOBIVAC® INTRA-TRAC®3 IS A SAFE CHOICE
Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
Requires only single-nostril administration—low dose of 0.5 mL
Available with Advanced Delivery Technology (ADT) that eliminates the possibility of accidental injection (Nobivac® Intra-Trac®3 ADT only)
ADMINISTRATION AND DOSAGE
Designed for intranasal use only with the enclosed applicators
Flexible dosing – For one 1 mL dose, rehydrate vaccine with 1 mL sterile diluent or for one 0.5 mL dose, rehydrate vaccine with 0.5 mL sterile diluent
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
Available in a variety of presentations: 25 x 1, 2 x 5, and 150 x 1 dose
PROMOTES A STRONGER IGA RESPONSE THAN SUBCUTANEOUS VACCINATION16,17
IgA on mucosal surfaces appears to be more important than systemic responses when it comes to protecting against respiratory pathogens 18,19
Prevents microbes from adhering to mucosal surfaces of the nose and throat
Helps clear microbes trapped in mucus at the point of entry
Eliminated Bordetella shedding in controlled challenge 9 weeks after vaccination16
Significantly reduced cough scores and days of coughing16
INTRANASAL VS. ORAL AND INJECTABLE
NOBIVAC® INTRA-TRAC®3 INTRANASAL OFFERS ADVANTAGES OVER ORAL AND INJECTABLE VACCINES
*Dant JC, Waszgis B, LaFleur RL, Xu Z, Tarpey I. Duration of Immunity for an Oral Bordetella Bronchiseptica Vaccine. ISCAID Proceedings, Portland, OR, 2018.
No items to show.
Loading…
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Pair Up for Protection
Infographic
When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients.